A.B. Madhankumar All publications ( 7 ) Madhankumar AB. Slagle-Webb B. Wang X. Yang QX. Antonetti DA. Miller PA. Sheehan JM. Connor JR. Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model. 2009 Mar. Mol Cancer Ther. 8(3):648-54. Fisher J. Devraj K. Ingram J. Slagle-Webb B. Madhankumar AB. Liu X. Klinger M. Simpson IA. Connor JR. Ferritin: a novel mechanism for delivery of iron to the brain and other organs. 2007 Aug. Am J Physiol Cell Physiol. 293(2):C641-9. Madhankumar AB. Slagle-Webb B. Mintz A. Sheehan JM. Connor JR. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. 2006 Dec. Mol Cancer Ther. 5(12):3162-9. Madhankumar AB. Mintz A. Debinski W. Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2. 2004 Jan-Feb. Neoplasia. 6(1):15-22. National Cancer Institute Mintz A. Gibo DM. Madhankumar AB. Debinski W. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma. 2003 Aug-Sep. J Neurooncol. 64(1-2):117-23. National Cancer Institute Madhankumar AB. Mintz A. Debinski W. Alanine-scanning mutagenesis of alpha-helix D segment of interleukin-13 reveals new functionally important residues of the cytokine. 2002 Nov 8. J Biol Chem. 277(45):43194-205. National Cancer Institute Madhan Kumar AB. Panduranga Rao K. Preparation and characterization of pH-sensitive proteinoid microspheres for the oral delivery of methotrexate. 1998 Apr-May. Biomaterials. 19(7-9):725-32.